Table 3.
Variable | S. pneumoniae serotype | |||
---|---|---|---|---|
7F (n=21) | 19A (n=6) | MRSA (n=4) | S.pyogenes (n=7) | |
Demographic Characteristics | ||||
Male sex | 10 (48%) | 4 (67%) | 4 (100%) | 5 (71%) |
Age months, median (range) | 43 (17–204) | 28 (17–43) | 182 (154–198) | 90 (24–168) |
Preexisting condition | 4 (19%) | 1 (17%) | 2 (50%) | 0 (0%) |
Admission Characteristics | ||||
Illness days, median (range) | 7 (3–16) | 4.5 (2–7) | 4 (2–5) | 5 (3–10) |
Antibiotic Pretreatment | 17 (81%) | 5 (83%) | 3 (75%) | 5 (71%) |
Positive Blood or PF culture | 8 (38%) | 5 (83%) | 4 (100%) | 3 (43%) |
Outcome | ||||
LOS days, median (range) | 10 (6–49) | 11.5 (9–16) | 21 (11–32) | 11 (4–30) |
Hospitalization in ICU | 5 (24%) | 5 (83%) | 2 (50%) | 4 (57%) |
Dual Infection1 | 3 (14%) | 0 (0%) | 1 (25%) | 3 (43%) |
Death | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Dual Infections included: S. pneumoniae and S. pyogenes (2); S. pneumoniae and S. aureus (MSSA; 2); S. pneumoniae and M. pneumoniae (1); S. aureus (MRSA) and S. pyogenes (1)